| Classifying prion and prion-like phenomena D Harbi, PM Harrison Prion 8 (2), 161-165, 2014 | 44 | 2014 |
| Integration of technical, bioinformatic, and variant assessment approaches in the validation of a targeted next-generation sequencing panel for myeloid malignancies M Thomas, MA Sukhai, T Zhang, R Dolatshahi, D Harbi, S Garg, ... Archives of Pathology and Laboratory Medicine 141 (6), 759-775, 2017 | 36 | 2017 |
| PrionHome: a database of prions and other sequences relevant to prion phenomena D Harbi, M Parthiban, DMA Gendoo, S Ehsani, M Kumar, G Schmitt-Ulms, ... PloS one 7 (2), e31785, 2012 | 30 | 2012 |
| LPS-annotate: complete annotation of compositionally biased regions in the protein knowledgebase D Harbi, M Kumar, PM Harrison Database 2011, baq031, 2011 | 25 | 2011 |
| Interaction networks of prion, prionogenic and prion-like proteins in budding yeast, and their role in gene regulation D Harbi, PM Harrison PloS one 9 (6), e100615, 2014 | 21 | 2014 |
| Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas S Harada, A Caliò, KM Janowski, D Morlote, MDR Pena, S Canete-Portillo, ... Modern Pathology 34 (11), 2055-2063, 2021 | 17 | 2021 |
| The interpretation of sequence variants in myeloid neoplasms: an ACLPS critical review M Hanbazazh, S Harada, V Reddy, AC Mackinnon, D Harbi, D Morlote American Journal of Clinical Pathology 156 (5), 728-748, 2021 | 2 | 2021 |
| Prospective next-generation sequencing molecular profiling of myeloid malignancies: assessment of information benefit and impact on patient care S Kamel-Reid, M Thomas, MA Sukhai, DL Barber, S Garg, M Misyura, ... Blood, The Journal of the American Society of Hematology 126 (23), 3848-3848, 2015 | 2 | 2015 |
| PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features of Lung Adenocarcinomas in Cytological Samples SA Anderson, D Harbi, D Oramas Mogrovejo, AD Floyd, IE Eltoum, ... Acta cytologica 67 (5), 507-518, 2023 | | 2023 |
| Validation and Performance of Fusion Gene Panel for MiT Family Translocation Renal Cell Carcinomas: Quality of RNA Is Important for Fusion Detection S Harada, K Janowski, D Morlote, MR Pena, D Harbi, A Calio, G DeFrank, ... JOURNAL OF MOLECULAR DIAGNOSTICS 22 (11), S58-S58, 2020 | | 2020 |
| Pindel as a Back-up INDEL Caller to a GATK4 Mutect2-Based in-House Developed Somatic Secondary Analysis Bioinformatics Pipeline for a Custom Clinical Cancer NGS Panel S Harada, D Harbi, E Iriabho, A Flannery, E Worthey, M Basu, ... JOURNAL OF MOLECULAR DIAGNOSTICS 22 (11), S52-S52, 2020 | | 2020 |
| Comparison of Targeted Myeloproliferative Subpanel versus Comprehensive Myeloid Panel in the Evaluation of Suspected BCR-ABL1-Negative Myeloproliferative Neoplasms D Morlote, F Fei, V Reddy, D Harbi, K Janowski, G DeFrank, A Mackinnon, ... JOURNAL OF MOLECULAR DIAGNOSTICS 22 (11), S24-S24, 2020 | | 2020 |
| Detection of Renal Cell Carcinoma with TFEB Amplification Using Archer FusionPlex RNASeq Gene Expression Data S Harada, K Janowski, MR Pena, D Harbi, A Calio, G DeFrank, D Morlote, ... JOURNAL OF MOLECULAR DIAGNOSTICS 22 (11), S71-S72, 2020 | | 2020 |
| Clinical testing and implementation of the TruSight Myeloid Next Generation Sequencing (NGS) panel for identification of clinically relevant variants in hematological malignancies M Thomas, M Sukhai, T Zhang, D Harbi, J De Souza, K MacDonald, ... Cancer Research 75 (15_Supplement), 4260-4260, 2015 | | 2015 |
| PrionOme: A database of prions and other sequences relevant to prion phenomena R Sowdhamini, P Harrison, D Harbi, M Parthiban, D Gendoo, S Ehsani, ... Nature Precedings, 1-1, 2011 | | 2011 |
| Developing the Prionome Database: A Prion Biology Resource D Harbi, M Parthiban, D Gendoo, S Ehsani, G Schmitt-Ulms, M Kumar, ... PRION 5, 48-49, 2011 | | 2011 |
